ACTH-derived heptapeptide for neuroresearch.
Semax is a synthetic heptapeptide analogue of an ACTH(4-10) fragment used in neuroscience research.
Modulates BDNF and dopaminergic/serotonergic systems in central nervous-system models.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Transcriptomic analysis of immune and vascular pathways under Semax following focal ischemia.
Attenuated pro-inflammatory cascade and modulated vascular remodeling genes.
Measured BDNF/NGF transcription under Semax and Pro-Gly-Pro after cerebral ischemia.
Activated neurotrophin and receptor gene transcription in penumbral tissue.
Reviewed molecular substrates of Semax's nootropic effects across studies.
Converging evidence for BDNF up-regulation and dopaminergic modulation.
Lyophilized -20°C.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — Semax is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.
